Hopp til hovedinnhold

Nevrosarkoidose

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Kidd DP. Neurosarcoidosis: clinical manifestations, investigation and treatment. Pract Neurol 2020. pmid:32424017 PubMed  
  2. Joseph FG, Scolding NJ. Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry 2009; 80: 297-304.
  3. Stern BJ1, Royal W 3rd2, Gelfand JM3, Clifford DB4, Tavee J5, Pawate S6, Berger JR7, Aksamit AJ8, Krumholz A9, Pardo CA1, Moller DR10, Judson MA, Drent M, Baughman RP. Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol 2018. pmid: 30167654 PubMed  
  4. Kidd DP et al. Optic neuropathy associated with systemic sarcoidosis. Neurol Neuroimmunol Neuroinflamm. 2016 Aug 2;3(5):e270. pmid:27536707 PubMed  
  5. Harris MJ, Cossburn MD, Pengas G. Multiple cerebral infarcts: a rare complication of neurosarcoidosis. Pract Neurol. 2019 Jun;19(3):246-249. PMID: 30700504 PubMed  
  6. Ljøstad U, Annertz M, Candale-Radu C, Mygland Å. Cerebral mikroangiopati ved nevrosarkoidose. Tidsskr Nor Laegeforen. 2019 Oct 14;139(15). PMID: 31642625 PubMed  
  7. Durel CA1,2, Marignier R3, Maucort-Boulch D4,5,6, Iwaz J4,5,6, Berthoux E7, Ruivard M8, André M9, Le Guenno G8, Pérard L10, Dufour JF11, Turcu A12, Antoine JC13, Camdessanche JP13, Delboy T14, Sève P15,4.. Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients.. J Neurol. 2016 May;263(5):981-90. . pmid:27007482 PubMed  
  8. Sechi E, Addis A, Piredda R, Rassu AL, Mameli G, Senes C, Sechi G. Longitudinally Extensive Spinal Cord Lesions Disclosing Occult Systemic Sarcoidosis. JAMA Neurol. 2016 Mar 14. doi: 10.1001/jamaneurol.2016.0013 . pmid:26974505 PubMed  
  9. Park BJ, Ray E, Bathla G, Bruch LA, Streit JA, Cho TA, Hitchon PW. Single Center Experience with Isolated Spinal Cord Neurosarcoidosis. World Neurosurg. 2021 Sep 25:S1878-8750(21)01432-7. PMID: 34583004. PubMed  
  10. Blazin T, Prajapati D, Mohammed LLM, Dhavale M, Abdelaal MK, Alam ABMN, Ballestas NP, Mostafa JA. Hypothalamic-Pituitary Axis Dysfunction, Central Diabetes Insipidus, and Syndrome of Inappropriate Antidiuretic Hormone Secretion as the First Clinical Presentation of Neurosarcoidosis: Why Early Diagnosis and Treatment is Important? Cureus. 2020 Nov 14;12(11):e11481. PMID: 33329977 PubMed  
  11. Hamodat H, Tran A. Neurosarcoidosis resulting in thoracic radiculopathy: a case report. J Med Case Rep. 2019 May 5;13(1):130. PMID: 31054576 PubMed  
  12. Singhal NS, Irodenko VS, Margeta M, Layzer RB. Sarcoid polyneuropathy masquerading as chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2015. pmid:25786655 PubMed  
  13. Oishi M, Mukaino A, Kunii M, Saito A, Arita Y, Koike H, Higuchi O, Maeda Y, Abiru N, Yamaguchi N, Kawano H, Tsuiki E, Tanaka T, Matsuo H, Katsuno M, Tanaka F, Tsujino A, Nakane S. Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies. J Neurol. 2021 Nov;268(11):4265-4279. doi: 10.1007/s00415-021-10551-4. Epub 2021 Apr 21. PMID: 33881596; PMCID: PMC8505292.
  14. Bradshaw MJ, Pawate S, Koth LL, Cho TA, Gelfand JM. Neurosarcoidosis: Pathophysiology, Diagnosis, and Treatment. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 4;8(6):e1084. PMID: 34607912 PubMed  
  15. Bathla G, Abdel-Wahed L, Agarwal A, Cho TA, Gupta S, Jones KA, Priya S, Soni N, Wasserman BA. Vascular Involvement in Neurosarcoidosis: Early Experiences From Intracranial Vessel Wall Imaging. Neurol Neuroimmunol Neuroinflamm. 2021 Aug 4;8(6):e1063. doi: 10.1212/NXI.0000000000001063. PMID: 34349028; PMCID: PMC8340434.
  16. Arun T, Pattison L, Palace J. . Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective study. . Neurology 2020. pmid:32354749 PubMed  
  17. Dhanapalaratnam R, Huynh W. . Clinicoradiological dissociation in sarcoid myelopathy. J Neurol Neurosurg Psychiatry 2020. pmid:32855287 PubMed  
  18. Curr Opin Neurol. 2013; 26: 307-13. Neurosarcoidosis: diagnostic approaches and therapeutic strategies. Segal BM. PMID: 23571775 PubMed  
  19. Khoury J, Wellik KE, Demaerschalk BM, Wingerchuk DM. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist 2009; 15: 108-11. PMID: 19276791 PubMed  
  20. Kidd DP. Management of neurosarcoidosis. J Neuroimmunol. 2022 Nov 15;372:577958. doi: 10.1016/j.jneuroim.2022.577958. Epub 2022 Sep 15. PMID: 36162337 PubMed  
  21. Arun T, Palace J. Effects of immunotherapies and clinical outcomes in neurosarcoidosis: a retrospective cohort study. J Neurol. 2021 Jan 30. doi: 10.1007/s00415-021-10421-z. Epub ahead of print. PMID: 33515298.
  22. Hilezian F, Maarouf A, Boutiere C, Rico A, Demortiere S, Kerschen P, Sene T, Bensa-Koscher C, Giannesini C, Capron J, Mekinian A, Camdessanché JP, Androdias G, Marignier R, Collongues N, Casez O, Coclitu C, Vaillant M, Mathey G, Ciron J, Pelletier J, Audoin B; Under the aegis of the French Multiple Sclerosis Society. TNF-α inhibitors used as steroid-sparing maintenance monotherapy in parenchymal CNS sarcoidosis. J Neurol Neurosurg Psychiatry. 2021 Jun 8;92(8):890–6. doi: 10.1136/jnnp-2020-325665. Epub ahead of print. PMID: 34103339; PMCID: PMC8292597.
  23. Hutto SK, Kyle K, Cavanagh JJ, Reda H, Venna N. Adalimumab for CNS sarcoidosis: single-center experience and literature review. J Neurol. 2021 Sep 6. PMID: 34487233. PubMed  
  24. Santos E, Shaunak S, Renowden S, Scolding NJ. Treatment of refractory neurosarcoidosis with Infliximab. J Neurol Neurosurg Psychiatry 2010; 81: 241-6. PubMed  
  25. Lorentzen AO, Sveberg L, Midtvedt O, Kerty E, Heuser K. Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice. Clin Neuropharmacol. 2014 ; Sep-Oct;37(5): 142-8. pmid:25229171 PubMed  
  26. Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S. Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series. Neurology. 2017 Oct 13. pmid:29030454 PubMed  
  27. Riller Q, Cotteret C, Junot H, Benameur N, Haroche J, Mathian A, Hie M, Miyara M, Tilleul P, Amoura Z, Cohen Aubart F. Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment. J Neurol. 2019 May;266(5):1073-1078. PMID: 30739183 PubMed  
  28. Lord J, Paz Soldan MM, Galli J, Salzman KL, Kresser J, Bacharach R, DeWitt LD, Klein J, Rose J, Greenlee J, Clardy SL. . Neurosarcoidosis: Longitudinal experience in a single-center, academic healthcare system. . Neurol Neuroimmunol Neuroinflamm 2020. pmid:32404428 PubMed  
  29. Bomprezzi R1, Pati S, Chansakul C, Vollmer T.. A case of neurosarcoidosis successfully treated with rituximab. Neurology. 2010; Aug 10;75(6):568-70.: :568-70. pmid:20697110 PubMed  
  30. Shenoy N, Tesfaye M, Brown J, Simmons N, Weiss D, Meholli M, Mabie P. Corticosteroid-resistant bulbar neurosarcoidosis responsive to intravenous immunoglobulin. Pract Neurol. 2015 Aug;15(4):289-92 . pmid:25935926 PubMed  
  • Åse Mygland, spesialist i nevrologi, professor dr med
  • Unn Ljøstad, spesialist i nevrolgi, professor PhD